All Phenotypes Map3k7<tm1Aki> MGI Mouse

Phenotypes associated with this allele

Jump to	Allelic Composition	Genetic Background	Genotype ID
cn1	Map3k7^tm1Aki/Map3k7^tm1Aki Tg(Lck-cre)1Jtak/0	involves: 129P2/OlaHsd	MGI:3664612
cn2	Map3k7^tm1Aki/Map3k7^tm1Aki Tnfrsf1a^tm1Mak/Tnfrsf1a^tm1Mak Tg(Tek-cre)12Flv/0	involves: 129P2/OlaHsd * 129S2/SvPas * C3H * C57BL/6	MGI:5464102
cn3	Map3k7^tm1Aki/Map3k7^tm1Aki Tg(Tek-cre)12Flv/0	involves: 129P2/OlaHsd * C3H * C57BL/6	MGI:5464101
cn4	Map3k7^tm1Aki/Map3k7^tm1Aki Tg(Lck-cre)1Jtak/0	involves: 129P2/OlaHsd * C57BL/6	MGI:5823990
cn5	Cd19^tm1(cre)Cgn/Cd19⁺ Map3k7^tm1Aki/Map3k7^tm1.1Aki	involves: 129P2/OlaHsd * C57BL/6	MGI:3664610
cn6	Map3k7^tm1Aki/Map3k7^tm1Aki Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺	involves: 129P2/OlaHsd * C57BL/6 * DBA/2	MGI:4461042
cn7	Map3k7^tm1Aki/Map3k7^tm1Aki Tg(Slco1c1-icre/ERT2)1Mrks/0	involves: 129P2/OlaHsd * C57BL/6 * DBA/2	MGI:5305853
cn8	Map3k7^tm1Aki/Map3k7^tm1Aki Tg(Slco1c1-icre/ERT2)1Mrks/0	involves: 129P2/OlaHsd * C57BL/6 * SJL	MGI:5305854
cn9	Map3k7^tm1Aki/Map3k7^tm1Aki Tg(Alb1-cre)7Gsc/0	involves: 129P2/OlaHsd * FVB/N	MGI:4461039
cn10	Ikbkg^tm1.1Chtr/Ikbkg^tm1.1Chtr Map3k7^tm1Aki/Map3k7^tm1Aki Tg(Alb1-cre)7Gsc/0	involves: 129P2/OlaHsd * FVB/N	MGI:4461041
cn11	Casp8^tm1Clie/Casp8^tm1Clie Map3k7^tm1Aki/Map3k7^tm1Aki Tg(Alb1-cre)7Gsc/0	involves: 129P2/OlaHsd * FVB/N	MGI:4461038

Allelic Composition	Map3k7^tm1Aki/Map3k7^tm1Aki Tg(Lck-cre)1Jtak/0
Genetic Background	involves: 129P2/OlaHsd

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Map3k7^tm1Aki mutation (0 available); any Map3k7 mutation (51 available)
Tg(Lck-cre)1Jtak mutation (3 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

immune system

colitis ( J:112837 )

• with mononuclear cell infiltration of the colon seen at 4 - 6 months of age

increased memory T cell number ( J:112837 )

• in older mice numbers of activated/memory T cells increases; however, these cells contain only unrecombined alleles

decreased T cell number ( J:112837 )

• markedly reduced numbers of peripheral T cells

• at 4 - 6 months of age almost no naive T cells are found in the spleen and lymph nodes

decreased CD4-positive, alpha-beta T cell number ( J:112837 )

• severe decrease in the number of CD24^low mature cells while the number of CD24^high immature cells is similar to controls

decreased CD8-positive, alpha-beta T cell number ( J:112837 )

• severe decrease in the number of CD24^low mature cells while the number of CD24^high immature cells is similar to controls

absent regulatory T cells ( J:112837 )

• no detectable regulatory T cells in the thymus or spleen at 6 weeks of age

decreased single-positive T cell number ( J:112837 )

• decreased numbers of single positive T cells, especially CD8+ cells, while the numbers of double negative and double positive T cells is similar to controls

abnormal spleen morphology ( J:112837 )

enlarged spleen ( J:112837 )

• seen at 4 - 6 months of age

spleen hyperplasia ( J:112837 )

• increase in the numbers of myeloid lineage cells (macrophages, neutrophils) but almost a complete absence of naive T cells is detected at 4 - 6 months of age

abnormal T cell activation ( J:112837 )

• dose-dependent induction of cell death in response to TNF stimulation unlike controls cells which are viable after TNF stimulation

decreased T cell proliferation ( J:112837 )

• impaired proliferation in response to anti-CD3 stimulation with or without co-stimulation by anti-CD28

enlarged lymph nodes ( J:112837 )

• seen at 4 - 6 months of age

digestive/alimentary system

abnormal intestine morphology ( J:112837 )

abnormal intestinal goblet cell morphology ( J:112837 )

• at 4 - 6 months of age, loss of goblet cells is seen in the large intestine but not in the small intestine

intestinal ulcer ( J:112837 )

• prominent ulceration is seen at 4 - 6 months of age in the large, but not the small, intestine

abnormal colon morphology ( J:112837 )

• stiff colon present at 4 - 6 months of age

rectal prolapse ( J:112837 )

• seen at 4 - 6 months of age

chronic diarrhea ( J:112837 )

• severe diarrhea beginning at 4 - 6 months of age

colitis ( J:112837 )

• with mononuclear cell infiltration of the colon seen at 4 - 6 months of age

growth/size/body

weight loss ( J:112837 )

• begins at 4 - 6 months of age

enlarged spleen ( J:112837 )

• seen at 4 - 6 months of age

spleen hyperplasia ( J:112837 )

• increase in the numbers of myeloid lineage cells (macrophages, neutrophils) but almost a complete absence of naive T cells is detected at 4 - 6 months of age

hematopoietic system

increased memory T cell number ( J:112837 )

• in older mice numbers of activated/memory T cells increases; however, these cells contain only unrecombined alleles

decreased T cell number ( J:112837 )

• markedly reduced numbers of peripheral T cells

• at 4 - 6 months of age almost no naive T cells are found in the spleen and lymph nodes

decreased CD4-positive, alpha-beta T cell number ( J:112837 )

• severe decrease in the number of CD24^low mature cells while the number of CD24^high immature cells is similar to controls

decreased CD8-positive, alpha-beta T cell number ( J:112837 )

• severe decrease in the number of CD24^low mature cells while the number of CD24^high immature cells is similar to controls

absent regulatory T cells ( J:112837 )

• no detectable regulatory T cells in the thymus or spleen at 6 weeks of age

decreased single-positive T cell number ( J:112837 )

• decreased numbers of single positive T cells, especially CD8+ cells, while the numbers of double negative and double positive T cells is similar to controls

abnormal spleen morphology ( J:112837 )

enlarged spleen ( J:112837 )

• seen at 4 - 6 months of age

spleen hyperplasia ( J:112837 )

• increase in the numbers of myeloid lineage cells (macrophages, neutrophils) but almost a complete absence of naive T cells is detected at 4 - 6 months of age

abnormal T cell activation ( J:112837 )

• dose-dependent induction of cell death in response to TNF stimulation unlike controls cells which are viable after TNF stimulation

decreased T cell proliferation ( J:112837 )

• impaired proliferation in response to anti-CD3 stimulation with or without co-stimulation by anti-CD28

cellular

abnormal intestinal goblet cell morphology ( J:112837 )

• at 4 - 6 months of age, loss of goblet cells is seen in the large intestine but not in the small intestine

decreased T cell proliferation ( J:112837 )

• impaired proliferation in response to anti-CD3 stimulation with or without co-stimulation by anti-CD28

Allelic Composition	Map3k7^tm1Aki/Map3k7^tm1Aki Tnfrsf1a^tm1Mak/Tnfrsf1a^tm1Mak Tg(Tek-cre)12Flv/0
Genetic Background	involves: 129P2/OlaHsd * 129S2/SvPas * C3H * C57BL/6

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Map3k7^tm1Aki mutation (0 available); any Map3k7 mutation (51 available)
Tg(Tek-cre)12Flv mutation (1 available)
Tnfrsf1a^tm1Mak mutation (2 available); any Tnfrsf1a mutation (47 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

embryonic lethality during organogenesis, complete penetrance ( J:191285 )

• mice die by E13.5

cardiovascular system

cardiovascular system phenotype ( J:191285 )

N	• blood vessels do not exhibit regression and exhibit normal vessel length and branching

dilated vasculature ( J:191285 )

cellular

cellular phenotype ( J:191285 )

N	• embryonic endothelial cell apoptosis is rescued

Allelic Composition	Map3k7^tm1Aki/Map3k7^tm1Aki Tg(Tek-cre)12Flv/0
Genetic Background	involves: 129P2/OlaHsd * C3H * C57BL/6

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Map3k7^tm1Aki mutation (0 available); any Map3k7 mutation (51 available)
Tg(Tek-cre)12Flv mutation (1 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

embryonic lethality during organogenesis, complete penetrance ( J:191285 )

• mice die between E10.5 and E11.5

cardiovascular system

cardiovascular system phenotype ( J:191285 )

N	• mice exhibit normal cardiac development

abnormal vascular development ( J:191285 )

• defective vascular development at E10.5 with disorganized vasculature and truncated capillary vessels

• however, development of the aorta is normal

decreased angiogenesis ( J:191285 )

• impaired vessel sprouting

abnormal vitelline vasculature morphology ( J:191285 )

• fewer vessel branches

embryo

abnormal vitelline vasculature morphology ( J:191285 )

• fewer vessel branches

cellular

increased apoptosis ( J:191285 )

• in embryonic endothelial cell

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

digestive/alimentary system

abnormal intestinal epithelium physiology ( J:238318 )

• increase in intestinal epithelial permeability indicating defective barrier function

colitis ( J:238318 )

• mice develop spontaneous colitis

• mice in which gut commensal bacteria is removed by treatment with four antibiotics do not exhibit colitis

• -6-8 week old mutants transferred with TCRalphabeta+CD8alpha+ IELS show significant amelioration of colitis, however transfer with CD8+ T or natural killer cells has no effect on colitis

hematopoietic system

abnormal T cell morphology ( J:238318 )

• drastic reduction in the frequency and absolute number of TCR beta+ T cells in the mesenteric lymph nodes

• however, the colonic lamina propria contains TCR beta+ T cells

• some mice have up to 10 times more T cells in colonic lamina propria than wild-type mice

increased CD4-positive, alpha-beta T cell number ( J:238318 )

• the majority of TCR alpha beta+ T cells in the mesenteric lymph nodes and colonic lamina propria are CD4+ T cells compared to wild-type mice

• accumulation of CD4+ T cells in the colonic lamina propria

decreased NK T cell number ( J:238318 )

• the TCR beta+NK1.1+ natural killer T cell population in the thymus and liver and alpha-GalCer/CD1d-reacted natural killer T cell population in the liver are hardly detectable in mice

abnormal intraepithelial T cell number ( J:238318 )

• reduction in the frequencies and absolute numbers of TCR beta+ intestinal intraepithelial lymphocytes (IEL) in both the small and large intestine

• both the CD8 alpha-alpha+ and CD8 alpha-beta+ cell populations of TCR beta+ IELs are almost completely absent

• the CD4+CD8 alpha-alpha+ cell population in TCR beta+CD8 beta- cells is decreased in the small and large intestine

• the colon exclusive TCR beta+CD4-CD8 alpha-CD8 beta- cell population is absent

• the remaining TCR beta+ IEL fraction is CD4+ T cells

• thymic IEL precursors (TCR alpha-beta+CD4-CD8-NK1.1-) are decreased in both frequency and absolute number; this reduction is due to almost complete loss of CD103+ cell population coexpressing both CD5 and CD122

increased gamma-delta intraepithelial T cell number ( J:238318 )

• increase in the frequency of TCR gamma-delta+ IELs in the small and large intestines and the absolute numbers of these IELs are increased in the colon but not the small intestine

abnormal regulatory T cell number ( J:238318 )

• frequency of regulatory T cells is higher in mesenteric lymph nodes and lower in colonic lamina propria in mice older than 10 weeks of age, however, absolute numbers of regulatory T cells are unchanged

decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number ( J:238318 )

• reduction in frequency of CD25+Foxp3+ cells in CD4 single positive thymocytes of 10 week old mice that do not have colitis

abnormal alpha-beta intraepithelial T cell morphology ( J:238318 )

• thymic IEL precursors (TCRalphabeta+CD4-CD8-NK1.1-) stimulated with an agonistic anti-CD3 antibody in vitro do not show enlargement of cell size and induced expression of CD25, IL-2Ralpha chain as seen in wild-type cells

• thymic IEL precursors treated with the agonistic anti-CD3 antibody show inefficient induction of CD8alpha induction

abnormal CD4-positive, alpha-beta T cell physiology ( J:238318 )

• CD4+ T cells from colonic lamina propria and mesenteric lymph nodes stimulated with PMA plus ionomycin exhibit a more robust production of IFN-gamma and IL-17A than in wild-type cells

abnormal regulatory T cell physiology ( J:238318 )

• in an in vitro suppression assay, regulatory T cells show less suppressive activity than wild-type T cells, indicating failure of suppressive function of the leaky regulatory T cells

homeostasis/metabolism

abnormal cytokine level ( J:238318 )

• colons show increased mRNA levels of proinflammatory cytokines and RegIII-beta/gamma proteins (antimicrobial peptides)

• elevation of expression of IFN-gamma and IL-17

immune system

colitis ( J:238318 )

• mice develop spontaneous colitis

• mice in which gut commensal bacteria is removed by treatment with four antibiotics do not exhibit colitis

• -6-8 week old mutants transferred with TCRalphabeta+CD8alpha+ IELS show significant amelioration of colitis, however transfer with CD8+ T or natural killer cells has no effect on colitis

abnormal T cell morphology ( J:238318 )

• drastic reduction in the frequency and absolute number of TCR beta+ T cells in the mesenteric lymph nodes

• however, the colonic lamina propria contains TCR beta+ T cells

• some mice have up to 10 times more T cells in colonic lamina propria than wild-type mice

increased CD4-positive, alpha-beta T cell number ( J:238318 )

• the majority of TCR alpha beta+ T cells in the mesenteric lymph nodes and colonic lamina propria are CD4+ T cells compared to wild-type mice

• accumulation of CD4+ T cells in the colonic lamina propria

decreased NK T cell number ( J:238318 )

• the TCR beta+NK1.1+ natural killer T cell population in the thymus and liver and alpha-GalCer/CD1d-reacted natural killer T cell population in the liver are hardly detectable in mice

abnormal intraepithelial T cell number ( J:238318 )

• reduction in the frequencies and absolute numbers of TCR beta+ intestinal intraepithelial lymphocytes (IEL) in both the small and large intestine

• both the CD8 alpha-alpha+ and CD8 alpha-beta+ cell populations of TCR beta+ IELs are almost completely absent

• the CD4+CD8 alpha-alpha+ cell population in TCR beta+CD8 beta- cells is decreased in the small and large intestine

• the colon exclusive TCR beta+CD4-CD8 alpha-CD8 beta- cell population is absent

• the remaining TCR beta+ IEL fraction is CD4+ T cells

increased gamma-delta intraepithelial T cell number ( J:238318 )

• increase in the frequency of TCR gamma-delta+ IELs in the small and large intestines and the absolute numbers of these IELs are increased in the colon but not the small intestine

abnormal regulatory T cell number ( J:238318 )

decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number ( J:238318 )

• reduction in frequency of CD25+Foxp3+ cells in CD4 single positive thymocytes of 10 week old mice that do not have colitis

abnormal alpha-beta intraepithelial T cell morphology ( J:238318 )

• thymic IEL precursors treated with the agonistic anti-CD3 antibody show inefficient induction of CD8alpha induction

abnormal CD4-positive, alpha-beta T cell physiology ( J:238318 )

• CD4+ T cells from colonic lamina propria and mesenteric lymph nodes stimulated with PMA plus ionomycin exhibit a more robust production of IFN-gamma and IL-17A than in wild-type cells

abnormal regulatory T cell physiology ( J:238318 )

• in an in vitro suppression assay, regulatory T cells show less suppressive activity than wild-type T cells, indicating failure of suppressive function of the leaky regulatory T cells

abnormal cytokine level ( J:238318 )

• colons show increased mRNA levels of proinflammatory cytokines and RegIII-beta/gamma proteins (antimicrobial peptides)

• elevation of expression of IFN-gamma and IL-17

increased interferon-gamma secretion ( J:238318 )

• CD4+ T cells from colonic lamina propria and mesenteric lymph nodes stimulated with PMA plus ionomycin exhibit a more robust production of IFN-gamma than in wild-type cells

increased interleukin-17 secretion ( J:238318 )

• CD4+ T cells from colonic lamina propria and mesenteric lymph nodes stimulated with PMA plus ionomycin exhibit a more robust production of IL-17A than in wild-type cells

liver/biliary system

abnormal liver morphology ( J:238318 )

• large numbers of bacteria are detected in the livers

Allelic Composition	Cd19^tm1(cre)Cgn/Cd19⁺ Map3k7^tm1Aki/Map3k7^tm1.1Aki
Genetic Background	involves: 129P2/OlaHsd * C57BL/6

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cd19^tm1(cre)Cgn mutation (11 available); any Cd19 mutation (56 available)
Map3k7^tm1.1Aki mutation (0 available); any Map3k7 mutation (51 available)
Map3k7^tm1Aki mutation (0 available); any Map3k7 mutation (51 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

immune system

decreased B-1 B cell number ( J:112597 )

• decrease in the number of B220+CD5+ B-1 B cells in the peritoneal cavity

abnormal B cell physiology ( J:112597 )

• impaired B cell survival following LPS or CpG DNA stimulation or B cell receptor crosslinking

decreased B cell proliferation ( J:112597 )

• decreased LPS- and/or CpG DNA-induced proliferation in follicular and marginal zone B-2 cells with impaired entry in S phase; however, LPS- and/or CpG DNA-induced IL6 production is similar to wild-type

• decreased proliferation in response to B cell receptor and CD40 stimulation with impaired entry into S phase and impaired survival following B cell receptor crosslinking

decreased immunoglobulin level ( J:112597 )

• decrease for all isotypes except IgM

decreased IgG level ( J:112597 )

• decreased levels of IgG1 and IgG3 following T cell dependent or T cell independent antigen stimulation, respectively; however, levels of IgM are similar to control following T cell dependent antigen stimulation

decreased IgG1 level ( J:112597 )

decreased IgG3 level ( J:112597 )

hematopoietic system

decreased B-1 B cell number ( J:112597 )

• decrease in the number of B220+CD5+ B-1 B cells in the peritoneal cavity

abnormal B cell physiology ( J:112597 )

• impaired B cell survival following LPS or CpG DNA stimulation or B cell receptor crosslinking

decreased B cell proliferation ( J:112597 )

• decreased proliferation in response to B cell receptor and CD40 stimulation with impaired entry into S phase and impaired survival following B cell receptor crosslinking

decreased immunoglobulin level ( J:112597 )

• decrease for all isotypes except IgM

decreased IgG level ( J:112597 )

decreased IgG1 level ( J:112597 )

decreased IgG3 level ( J:112597 )

cellular

decreased B cell proliferation ( J:112597 )

• decreased proliferation in response to B cell receptor and CD40 stimulation with impaired entry into S phase and impaired survival following B cell receptor crosslinking

Allelic Composition	Map3k7^tm1Aki/Map3k7^tm1Aki Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺
Genetic Background	involves: 129P2/OlaHsd * C57BL/6 * DBA/2

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Map3k7^tm1Aki mutation (0 available); any Map3k7 mutation (51 available)
Speer6-ps1^{Tg(Alb-cre)21Mgn} mutation (6 available); any Speer6-ps1 mutation (4 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

liver/biliary system

focal hepatic necrosis ( J:160521 )

increased hepatocyte proliferation ( J:160521 )

abnormal bile duct morphology ( J:160521 )

• mice exhibit areas of ductopenia within some portal tracts unlike wild-type mice

abnormal hepatocyte morphology ( J:160521 )

homeostasis/metabolism

increased circulating bilirubin level ( J:160521 )

• mild

endocrine/exocrine glands

abnormal bile duct morphology ( J:160521 )

• mice exhibit areas of ductopenia within some portal tracts unlike wild-type mice

cellular

focal hepatic necrosis ( J:160521 )

increased hepatocyte proliferation ( J:160521 )

Allelic Composition	Map3k7^tm1Aki/Map3k7^tm1Aki Tg(Slco1c1-icre/ERT2)1Mrks/0
Genetic Background	involves: 129P2/OlaHsd * C57BL/6 * DBA/2

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Map3k7^tm1Aki mutation (0 available); any Map3k7 mutation (51 available)
Tg(Slco1c1-icre/ERT2)1Mrks mutation (0 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

behavior/neurological

behavior/neurological phenotype ( J:179050 )

N	• intravenous administration of IL-1beta induces reduction in food intake (IL-1beta-induced anorexia over 22 hours; this is similar to response of control mice

lethargy ( J:179050 )

• mutants exhibit reduced lethargy relative to controls in response to intravenous IL-1beta administration

decreased locomotor activity ( J:179050 )

• injection of IL-1beta at 10 am reduced spontaneous locomotion in mutants the next night, response is weaker than in controls

homeostasis/metabolism

homeostasis/metabolism phenotype ( J:179050 )

N	• mice have normal body temperature • corticosterone plasma levels rise to same extent as controls in response to IL-1beta administration

impaired febrile response ( J:179050 )

• IL-1beta induces only a short-lasting fever response in mutants compared to controls; however, early fever response remains intact

growth/size/body

growth/size/body region phenotype ( J:179050 )

N	• intravenous administration of IL-1beta induces weight loss in mutants over 22 hours; this is similar to response of control mice

Allelic Composition	Map3k7^tm1Aki/Map3k7^tm1Aki Tg(Slco1c1-icre/ERT2)1Mrks/0
Genetic Background	involves: 129P2/OlaHsd * C57BL/6 * SJL

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Map3k7^tm1Aki mutation (0 available); any Map3k7 mutation (51 available)
Tg(Slco1c1-icre/ERT2)1Mrks mutation (0 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

behavior/neurological

behavior/neurological phenotype ( J:179050 )

N	• in response to IL-1beta administration, inhibition of locomotion is similar in mutants and controls

homeostasis/metabolism

homeostasis/metabolism phenotype ( J:179050 )

N	• induced fever response to IL-1beta administration is similar to controls

Allelic Composition	Map3k7^tm1Aki/Map3k7^tm1Aki Tg(Alb1-cre)7Gsc/0
Genetic Background	involves: 129P2/OlaHsd * FVB/N

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Map3k7^tm1Aki mutation (0 available); any Map3k7 mutation (51 available)
Tg(Alb1-cre)7Gsc mutation (1 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

premature death ( J:160521 )

• mice die between 14 and 36 weeks

liver/biliary system

increased hepatocyte apoptosis ( J:160521 )

increased hepatocyte proliferation ( J:160521 )

abnormal bile duct morphology ( J:160521 )

• at 6 to 8 weeks, mice lack biliary epithelial cells and regularly shaped small bile ducts compared with wild-type mice

• biliary ductopenia is pronounced within areas of hepatocyte dysplasia

bile duct proliferation ( J:160521 )

liver inflammation ( J:160521 )

abnormal liver morphology ( J:160521 )

• numerous small visible nodules at 6 weeks

• larger nodules and an icteric appearance at 20 weeks

• nodules display cellular features of dysplasia like anisokaryosis unlike wild-type cells

• at 14 weeks, livers exhibit an increase in hydroproline content compared with wild-type liver

focal hepatic necrosis ( J:160521 )

abnormal hepatocyte morphology ( J:160521 )

• biliary ductopenia is pronounced within areas of hepatocyte dysplasia

liver fibrosis ( J:160521 )

• at 6 weeks, mice exhibit periportal liver fibrosis unlike wild-type mice

• at 20 to 29 weeks, mice exhibit severe diffuse fibrosis unlike wild-type mice

increased hepatocellular carcinoma incidence ( J:160521 )

• starting at 6 weeks

• in 14 of 16 mice at 16 to 33 weeks

intrahepatic cholestasis ( J:160521 )

homeostasis/metabolism

increased circulating bilirubin level ( J:160521 )

• at 6 weeks and further at 20 weeks

increased circulating alanine transaminase level ( J:160521 )

• at 6 and 20 weeks

increased circulating alkaline phosphatase level ( J:160521 )

• at 6 weeks

increased circulating aspartate transaminase level ( J:160521 )

• at 6 and 20 weeks

increased circulating glutamate dehydrogenase level ( J:160521 )

• at 6 weeks, circulating glutamate dehydrogenase is increased compared to in wild-type mice

neoplasm

increased hepatocellular carcinoma incidence ( J:160521 )

• starting at 6 weeks

• in 14 of 16 mice at 16 to 33 weeks

immune system

liver inflammation ( J:160521 )

endocrine/exocrine glands

abnormal bile duct morphology ( J:160521 )

• at 6 to 8 weeks, mice lack biliary epithelial cells and regularly shaped small bile ducts compared with wild-type mice

• biliary ductopenia is pronounced within areas of hepatocyte dysplasia

bile duct proliferation ( J:160521 )

cellular

increased hepatocyte apoptosis ( J:160521 )

focal hepatic necrosis ( J:160521 )

increased hepatocyte proliferation ( J:160521 )

Allelic Composition	Ikbkg^tm1.1Chtr/Ikbkg^tm1.1Chtr Map3k7^tm1Aki/Map3k7^tm1Aki Tg(Alb1-cre)7Gsc/0
Genetic Background	involves: 129P2/OlaHsd * FVB/N

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ikbkg^tm1.1Chtr mutation (0 available); any Ikbkg mutation (15 available)
Map3k7^tm1Aki mutation (0 available); any Map3k7 mutation (51 available)
Tg(Alb1-cre)7Gsc mutation (1 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

mortality/aging ( J:160521 )

N	• mice exhibit normal survival throughout 50 weeks

liver/biliary system

liver/biliary system phenotype ( J:160521 )

N	• bile ducts are normal at 6 weeks

increased hepatocyte apoptosis ( J:160521 )

increased hepatocyte proliferation ( J:160521 )

homeostasis/metabolism

homeostasis/metabolism phenotype ( J:160521 )

N	• mice exhibit normal bilirubin serum levels

increased circulating alanine transaminase level ( J:160521 )

increased circulating aspartate transaminase level ( J:160521 )

cellular

increased hepatocyte apoptosis ( J:160521 )

increased hepatocyte proliferation ( J:160521 )

Allelic Composition	Casp8^tm1Clie/Casp8^tm1Clie Map3k7^tm1Aki/Map3k7^tm1Aki Tg(Alb1-cre)7Gsc/0
Genetic Background	involves: 129P2/OlaHsd * FVB/N

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Casp8^tm1Clie mutation (0 available); any Casp8 mutation (42 available)
Map3k7^tm1Aki mutation (0 available); any Map3k7 mutation (51 available)
Tg(Alb1-cre)7Gsc mutation (1 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

mortality/aging ( J:160521 )

N	• mice exhibit normal survival throughout 40 weeks

liver/biliary system

abnormal bile duct morphology ( J:160521 )

• mice exhibit strong dysplasia, absence of small bile ducts, and increased bile duct proliferation compared with wild-type mice

bile duct proliferation ( J:160521 )

abnormal liver morphology ( J:160521 )

• mice exhibit hyperproliferation, dysplasia, and reduction of biliary epithelial cells unlike wild-type mice

focal hepatic necrosis ( J:160521 )

• at an earlier age and to a larger extent than in Map3k7^tm1Aki/ Map3k7^tm1Aki Tg(Alb1-cre)7Gsc mice

homeostasis/metabolism

increased circulating bilirubin level ( J:160521 )

• serum bilirubin levels are increased compared to in wild-type mice and Map3k7^tm1Aki/ Map3k7^tm1Aki Tg(Alb1-cre)7Gsc mice

increased circulating alanine transaminase level ( J:160521 )

• milder than in Map3k7^tm1Aki/ Map3k7^tm1Aki Tg(Alb1-cre)7Gsc mice

increased circulating aspartate transaminase level ( J:160521 )

growth/size/body

postnatal growth retardation ( J:160521 )

endocrine/exocrine glands

abnormal bile duct morphology ( J:160521 )

• mice exhibit strong dysplasia, absence of small bile ducts, and increased bile duct proliferation compared with wild-type mice

bile duct proliferation ( J:160521 )

cellular

focal hepatic necrosis ( J:160521 )

• at an earlier age and to a larger extent than in Map3k7^tm1Aki/ Map3k7^tm1Aki Tg(Alb1-cre)7Gsc mice

Contributing Projects: Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support.	last database update 04/30/2024 MGI 6.23